Cargando…
Supplemental Treatment for Huntington’s Disease with miR-132 that Is Deficient in Huntington’s Disease Brain
Huntington’s disease (HD) is an intractable neurodegenerative disorder caused by mutant Huntingtin (HTT) proteins that adversely affect various biomolecules and genes. MicroRNAs (miRNAs), which are functional small non-coding RNAs, are also affected by mutant HTT proteins. Here, we show amelioration...
Autores principales: | Fukuoka, Masashi, Takahashi, Masaki, Fujita, Hiromi, Chiyo, Tomoko, Popiel, H. Akiko, Watanabe, Shoko, Furuya, Hirokazu, Murata, Miho, Wada, Keiji, Okada, Takashi, Nagai, Yoshitaka, Hohjoh, Hirohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852323/ https://www.ncbi.nlm.nih.gov/pubmed/29858092 http://dx.doi.org/10.1016/j.omtn.2018.01.007 |
Ejemplares similares
-
Specific Inhibition of Tumor Cells by Oncogenic EGFR Specific Silencing by RNA interference
por: Takahashi, Masaki, et al.
Publicado: (2013) -
A novel form of necrosis, TRIAD, occurs in human Huntington’s disease
por: Yamanishi, Emiko, et al.
Publicado: (2017) -
Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY
por: Orth, Michael, et al.
Publicado: (2011) -
Neuropsychiatry of Huntington's disease
por: Rosenblatt, Adam
Publicado: (2007) -
Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)